AMGN vs WST
By Alex · Tickerpine
Amgen Inc. vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | WST |
|---|---|---|
| Price | $416.18 | $352.29 |
| Market cap | $225.15B | $24.79B |
| P/E ratio | 25.7 | 45.0 |
| ROE | 91.47% | 19.09% |
| Profit margin | 22.95% | 16.98% |
| Revenue growth | 9.50% | 13.80% |
| Dividend yield | 2.43% | 0.25% |
| Beta | 0.41 | 1.14 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs WST in plain English
- AMGN is the bigger company — about 9.1× the market cap of WST.
- AMGN is cheaper on earnings (P/E 25.7 vs 45.0).
- AMGN earns a higher return on equity (91% vs 19%).
- WST is growing revenue faster (14% vs 10%).
- AMGN has the higher dividend yield (2.43% vs 0.25%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.